Superior immunogenicity of HCV envelope glycoproteins when adjuvanted with cyclic-di-AMP, a STING activator or archaeosomes
Keywords: Vaccine; Adjuvant; HCV rE1E2 glycoproteins; c-di-AMP; Archaeosomes;